A Phase I, Randomized, Multiple-Dose Study to Evaluate the Pharmacokinetic Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Feb 2015
Price : $35 *
At a glance
- Drugs Samatasvir (Primary) ; Simeprevir (Primary) ; TMC 647055 (Primary) ; Ritonavir
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Idenix Pharmaceuticals; Merck Sharp & Dohme
- 28 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Aug 2013 New trial record